International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
A Simple Calf, Hamstring & Low Back Relief Routine for Patients With Cancer
2
FDA Approves Sarclisa Escena as a New Under the Skin Treatment Option for Multiple Myeloma
3
GLP-1s: Weight Loss and Survival in Breast Cancer Recovery
4
FDA Approves Keytruda-Based Combination Before and After Surgery for Muscle-Invasive Bladder Cancer
5